Former lawyer Teresa Spehar, PhD, filed the lawsuit Sept. 7 after being fired from her post as the company’s vice president of intellectual property. The complaint alleges Dr. Spehar and other women received less pay than male employees, less frequent promotions, exclusion from meetings and were “challenged or denigrated with gender-based stereotypes.”
As of 2 p.m. PT Sept. 19, Synthetic Genomics had not been served with the lawsuit, which the company said it plans to fight.
“While I cannot specifically comment on ongoing litigation, what I can tell you is I passionately believe it is without merit and we will vigorously defend the claims made in the lawsuit,” Synthetic Genomics CEO Oliver Fetzer, PhD, said in an emailed response to The San Diego Union-Tribune.
More articles on data analytics and precision medicine:
NSF awards UCLA, Claremont McKenna College $800k for big data Lyme disease research
Boston consulting group to study pneumonia care with EHR data
IBM health officer heads to Cota as CMO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.